Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of CD44+ALDH1+Ki-67- Cells in Non-malignant and Neoplastic Lesions of the Breast.

Anticancer research - 1 Sept 2016

DA Cruz Paula Arnaud, Marques Oriana, Sampaio Rita, Rosa Ana, Garcia José, Rêma Alexandra, DE Fátima Faria Maria, Silva Paula, Vizcaíno Ramón, Lopes Carlos

Abstract excerpt

BACKGROUND: Cancer stem cells are tumor cells that present self-renewal, clonal tumor initiation capacity and clonal long-term repopulation potential. We have previously demonstrated that the co-expression of the breast cancer stem cell (BCSC) markers hyaluronan receptor (CD44) and aldehyde dehydrogenase-1 (ALDH1) in ductal carcinomas in situ could be determinant for disease progression. Combining these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aldehyde Dehydrogenase 1 Family
Share to Breast

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Ductal, Breast

Share to Hyaluronan Receptors

Share to Ki-67 Antigen

Share to Neoplasm Metastasis

Share to Receptor, ErbB-2

Share to Retinal Dehydrogenase

Source

Identifiers

PMID: 27630305
DOI: 10.21873/anticanres.11013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of CD44+ALDH1+Ki-67- Cells in Non-malignant and Neoplastic Lesions of the Breast.PMID 27630305Read ↗

Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.Semantic proximity Read ↗

In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor PrognosisSemantic proximity Read ↗

High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas.Semantic proximity Read ↗

Cancer stem cells and their implication in breast cancer.Semantic proximity Read ↗

Heterogeneity of normal human breast stem and progenitor cells as revealed by transcriptional profilingSemantic proximity Read ↗

Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic StrategiesSemantic proximity Read ↗

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.Semantic proximity Read ↗

Novel molecular regulators of breast cancer stem cell plasticity and heterogeneitySemantic proximity Read ↗

Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cellsSemantic proximity Read ↗

Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype.Semantic proximity Read ↗

Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling.Semantic proximity Read ↗

Cross talk between tumor stroma and cancer cells plays a critical role in progressive enrichment of cancer stem cell phenotype in primary breast tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.